Medibord receives £75,000 investment
Mobius Life Sciences Fund is to invest £75,000 in Nottingham-based Medibord, a medical technology company that designs and manufactures patient positioning boards for use in MRI scanners and radiotherapy treatments.
Based in BioCity Nottingham, Medibord will invest the funds into its first radio translucent product, which it says was developed in response to oncologists calling for greater treatment accuracy, especially for prostate cancer.
The company is planning to expand into the Middle East, followed by the United States and European markets.
Chief executive of Medibord, Jonathan Richards, said: “With their expertise, contacts and medical sector knowledge, Mobius Life Sciences will bring more than money to Medibord.
“Mobius will help build our credibility and bolster our ability to move further and faster with our research and development, and will enable us to look beyond the UK market much sooner than we anticipated.”
